Rosendo Garganta

Rosendo Garganta has worked in various companies, universities, and business programs over the past decade. From 2009 to 2011, they were the Manager of Business Development at SISEMED. From 2011 to 2012, they were the General Partner at Medex Partners. In 2012, they became the Chief Executive Officer of Devicare. Since 2015, they have been a Visiting Associate Professor at various universities and business programs, including Universitat Politècnica de Catalunya (UPC), Universitat Pompeu Fabra (UPF), Centro de Estudios Superiores de la Industria Farmacéutica (CESIF), and EUNCET Business School. Rosendo has also collaborated with business acceleration programs in Biotech, such as CaixaImpulse from CaixaBank and d-HEALTH Barcelona from Biocat.

Rosendo Garganta has a diverse educational background. Rosendo completed a Bachelor in Industrial Engineering and a Bachelor in Automatics and Electronic Engineering from the Universitat Politècnica de Catalunya in 2009. Rosendo then went on to earn a Master in Business Administration (MBA) from EUNCET in 2011, followed by a Master in International Business Administration (MIBA) from EUNCET in 2012. In 2013, they completed the BioEmprendedor XXI Program from Biocat, BioRegion of Catalonia and the EMPENTA Program from Esade. In 2014, they completed the Ignite Fast Track Program from the University of Cambridge. In 2020, they completed the Private Equity and Venture Capital Course from Università Bocconi.